DK1939288T3 - T-celleadhæsionsmolekyle og antistof, der er rettet mod molekylet - Google Patents

T-celleadhæsionsmolekyle og antistof, der er rettet mod molekylet

Info

Publication number
DK1939288T3
DK1939288T3 DK06810939.6T DK06810939T DK1939288T3 DK 1939288 T3 DK1939288 T3 DK 1939288T3 DK 06810939 T DK06810939 T DK 06810939T DK 1939288 T3 DK1939288 T3 DK 1939288T3
Authority
DK
Denmark
Prior art keywords
molecule
directed against
cell adhesion
antibody directed
adhesion molecule
Prior art date
Application number
DK06810939.6T
Other languages
English (en)
Inventor
Hideaki Kan Ogasawara
Keiko Kan Mizuno
Yoshihisa Kan Arita
Miyuki Kan Nishimura
Toshio Kan Imai
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of DK1939288T3 publication Critical patent/DK1939288T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK06810939.6T 2005-09-29 2006-09-29 T-celleadhæsionsmolekyle og antistof, der er rettet mod molekylet DK1939288T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005285194 2005-09-29
PCT/JP2006/319576 WO2007037430A1 (ja) 2005-09-29 2006-09-29 Ｔ細胞接着分子およびそれに対する抗体

Publications (1)

Publication Number Publication Date
DK1939288T3 true DK1939288T3 (da) 2013-03-11

Family

ID=37899850

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06810939.6T DK1939288T3 (da) 2005-09-29 2006-09-29 T-celleadhæsionsmolekyle og antistof, der er rettet mod molekylet

Country Status (17)

Country Link
US (1) US20090181025A1 (da)
EP (1) EP1939288B1 (da)
JP (1) JP5106111B2 (da)
KR (1) KR101026016B1 (da)
CN (1) CN101316930B (da)
AU (1) AU2006295717B2 (da)
BR (1) BRPI0616438A2 (da)
CA (1) CA2624135C (da)
DK (1) DK1939288T3 (da)
ES (1) ES2400520T3 (da)
HK (1) HK1119448A1 (da)
IL (2) IL190488A (da)
MY (1) MY150639A (da)
NO (1) NO20081503L (da)
NZ (1) NZ567043A (da)
RU (1) RU2396275C2 (da)
WO (1) WO2007037430A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010123119A1 (ja) * 2009-04-23 2010-10-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 炎症性腸疾患治療剤およびそのスクリーニング方法
AR104833A1 (es) * 2015-07-01 2017-08-16 Syngenta Participations Ag Composiciones y métodos para controlar plagas de plantas
JP7280586B2 (ja) * 2018-10-15 2023-05-24 学校法人東京理科大学 樹状細胞の成熟抑制剤及び成熟抑制方法、並びに医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH0373280A (ja) 1989-03-20 1991-03-28 Kunii Nakada タガネ及びその装着用ホルダー
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
AU633698B2 (en) 1990-01-12 1993-02-04 Amgen Fremont Inc. Generation of xenogeneic antibodies
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
EP0754225A4 (en) 1993-04-26 2001-01-31 Genpharm Int HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS
CA2375493A1 (en) * 1999-06-17 2000-12-28 Incyte Genomics, Inc. Human transport proteins
AU7079300A (en) * 1999-08-31 2001-03-26 Genentech Inc. Compositions and methods for the treatment of immune related diseases
JP2004524001A (ja) * 2000-01-25 2004-08-12 ハイセック，インコーポレーテッド 白血球免疫グロブリン受容体（ｌｉｒ様）ポリペプチドおよびポリヌクレオチドに関する方法と材料
AU2001233003B2 (en) * 2000-01-25 2006-02-09 Arca Biopharma, Inc. Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
US20030187201A1 (en) * 2000-09-15 2003-10-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
KR20080068039A (ko) 2008-07-22
ES2400520T3 (es) 2013-04-10
NO20081503L (no) 2008-06-30
NZ567043A (en) 2012-08-31
IL190488A0 (en) 2008-11-03
CN101316930A (zh) 2008-12-03
CA2624135A1 (en) 2007-04-05
RU2008116833A (ru) 2009-11-10
BRPI0616438A2 (pt) 2012-12-25
CA2624135C (en) 2015-06-30
CN101316930B (zh) 2013-06-19
RU2396275C2 (ru) 2010-08-10
WO2007037430A1 (ja) 2007-04-05
AU2006295717A1 (en) 2007-04-05
EP1939288B1 (en) 2012-12-19
HK1119448A1 (en) 2009-03-06
IL211031A0 (en) 2011-04-28
MY150639A (en) 2014-02-14
JPWO2007037430A1 (ja) 2009-04-16
EP1939288A1 (en) 2008-07-02
JP5106111B2 (ja) 2012-12-26
IL190488A (en) 2016-09-29
KR101026016B1 (ko) 2011-03-30
EP1939288A4 (en) 2010-05-26
US20090181025A1 (en) 2009-07-16
AU2006295717B2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
DK1838733T3 (da) Antistoffer rettet mod angiopoietin-2 og anvendelser deraf
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
DK1927638T3 (da) Tætningsbånd og fiberprodukt, der gør brug af samme
DK2468732T3 (da) 1H-Quinazolin-2,4-dioner
ATE503759T1 (de) 7-ä2-ä4-(6-fluor-3-methyl-1,2-benzisoxazol-5-yl - 1-piperazinylüethylü-2-(1-propinyl)-7h-pyrazolo
DK1899377T3 (da) Humaniserede antistoffer, der er specifikke for NOGO-A, og farmaceutiske anvendelser deraf.
DK1939288T3 (da) T-celleadhæsionsmolekyle og antistof, der er rettet mod molekylet
FI20055133A (fi) Iskulaite
FIU20060368U0 (fi) Kansi, jossa on sulkuelementti
ES1058958Y (es) Mastil perfeccionado.
ITPR20050013A1 (it) Trattenitore particolati.
ES1056663Y (es) Abrazadera.
ES1058754Y (es) Precinto perfeccionado.
ES1056921Y (es) Cinta flocada.
AT504263A3 (de) Tunnel mit tübbingen, tübbing und dichthaut
ES1058235Y (es) Cañon pirotecnico perfeccionado.
ES1061025Y (es) Cubitera perfeccionada.
ES1059848Y (es) Fiambrera perfeccionada.
ES1060923Y (es) Tarima perfeccionada.
ES1057970Y (es) Pieza constructiva tipo sandwich.
ES1057969Y (es) Pieza constructiva tipo sandwich.
TH124200B (th) สารยับยั้งอันตรกิริยาระหว่าง mdm2 และ p53
ES1057126Y (es) Pulidora-abrillantadora perfeccionada.
ES1056712Y (es) Columpio perfeccionado.
ES1058535Y (es) Balaustrada perfeccionada.